Circulating Tumor Cells

Our inaugural Circulating Tumour Cells 2012 conference is expanding on the interest expressed in the CTC sessions of our very popular Single Cell Analysis conferences.

With oncologists increasingly using CTCs to gather prognostic information on their patients, it is more and more apparent that CTCs can offer clinicians a non-invasive means of sampling for genetic markers, monitoring treatment responsiveness, aiding in treatment decision-making and indicating novel drug targets.
However, there are still issues and questions being raised about the clinical significance of CTCs, as well as the need to improve sensitivity, reproducibility and reliability of their use in disease monitoring. To solve these problems there is a real need for increased collaboration and understanding if the industry is to effectively use CTCs to improve cancer survival rates and provide significant cost-savings.

The Circulating Tumor Cells 2012 conference and exhibition offers delegates 2 days of world class speakers who are at the forefront of the field and whose talks will be exploring, as well as attempting to answer, some of these CTC questions.

Running alongside the conference will be an exhibition covering the latest technological advances and associated services within these fields.

Keynote Speakers

Stefanie Jeffrey
Chief of Surgical Oncology Research, Stanford University School of Medicine

Brian Kirby
Head, Cornell University

Katharina Pachmann
Senior Researcher, SIMFO GmbH

Agenda Topics

CTCs as Prognostic or Predictive Biomarkers for Cancer
Early Cancer Detection
EMT in Cell Generation and Survival
Isolation and Analysis of CTCs: Emerging Technologies Impacting the Field
Methods of Enumeration of CTCs as a Predictor
Significance of CTCs in Various Types of Cancer: Liquid Tumors vs. Solid Tumors
The use of Circulating Tumor Cells in Clinical Development
Understanding the Role of EMT in Metastasis

Sponsorship and Exhibition Opportunities

Aaron Woodley, Exhibition Manager
a.woodley@selectbiosciences.com
+44 (0)1787 315129

Distinguished Faculty

Denis Smirnov, Associate Director, On Q Ity
Daniel Boffa, Assistant Professor of Surgery, Yale School of Medicine
Catherine Alix-Panabières, Associate Professor, University Medical Center of Montpellier
Dario Marchetti, Professor/Director, Baylor College of Medicine
Gavin Robertson, Director, Penn State Melanoma Center
Powrnima Joshi, Research Fellow, Lerner Research Institute/Cleveland Clinic Foundation
James Reuben, Full Professor, UT MD Anderson Cancer Center
Jeffrey Chalmers, Professor, Ohio State University
Peter Kuhn, Group Leader, Kuhn Laboratory, Scripps Research Institute
Marek Malecki, Director, Western University of Health Sciences
John Zhang, Associate Professor, The University of Texas at Austin
Wolfgang Janni, Head of Obsterics and Gynecology Dpt, University of Düsseldorf
Michael King, Associate Professor, Cornell University
Lihua Wang, Senior Scientist, The National Cancer Institute/National Institutes of Health
Minetta Liu, Associate Professor, Georgetown University Medical Center
Natalia Malara, , University Magna Graecia